Sort by Year
Chen L, Nikolic D, Li G, Liu J, van Breemen RB. In vitro inhibition of human cytochrome P450 enzymes by licoisoflavone B from Glycyrrhiza uralensis Fisch. ex DC. Toxicol. Sci. 2023 Aug 3:kfad079. doi: 10.1093/toxsci/kfad079
Smith DJ, Bi H, Hamman J, Ma X, Mitchell C, Nyirenda K, Monera-Penduka T, Oketch-Rabah H, Paine MF, Pettit S, Pheiffer W, Van Breemen RB, Embry M. Potential pharmacokinetic interactions with concurrent use of herbal medicines and a ritonavir-boosted COVID-19 protease inhibitor in low and middle-income countries. Front. Pharmacol. 2023; 14:1210579. doi: 10.3389/fphar.2023.1210579
van Breemen RB, Simchuk D. Antiviral activities of hemp cannabinoids. Clin. Sci. (Lond). 2023; 137(8):633-643. doi: 10.1042/CS20220193
Liu J, Banuvar S, Viana M, Barengolts E, Chen SN, Pauli GF, van Breemen RB. Pharmacokinetic interactions of a licorice dietary supplement with cytochrome P450 enzymes in female participants. Drug Metab. Dispos. 2023; 51(2):199-204. doi: 10.1124/dmd.122.001050
